Navigation Links
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
Date:11/11/2009

BOSTON, Nov. 11 /PRNewswire/ -- The Endovascular Forum (EVF), an IC Sciences company, announces today a new partnership with the Global Embolization Symposium and Technologies (GEST), and the launch of a dynamic online case-based interactive forum.

This endeavor is in line with the GEST mission and aim of bringing practitioners the highest level of scientific and technical education about the use of new materials and devices, their results, relevance for patient care, imaging, and to fine tune existing skills and expertise in these areas in the most innovative and dynamic method possible.

"This partnership between GEST, the world's leader in innovative and comprehensive forum for embolization science and education, and the Endovascular Forum, the premier innovative online community for endovascular physicians, is a beautiful match," said Dr. Ziv Haskal, one of the three co-founders of GEST. "We are very excited about linking our community with the far reach and vision of the EVF."

Embolization is one of the few areas in endovascular therapy that draws together all practitioners, regardless of their individual subspecialty practices. Obviously, for the interventional oncologist, embolization is the sine qua non. However, embolization spans peripheral vascular disease, trauma, visceral artery and venous interventions, pediatric and neurointerventional therapies, women's health, aortic disease, vascular malformations, gastrointestinal bleeding, liver disease, non-vascular procedures, cell-based therapies, etc.

In turn embolotherapy has become a central part of daily Interventional Radiology work. Embolization indications have substantially increased over the last decade and continue to do so. Fibroid embolization, trauma, and GI-hemorrhage are only a few areas manifesting this fast increase. Additionally, treatment of vascular malformations is fully dependent on embolization techniques. Oncology treatment with drug-eluting and target-specific beads is another fast-growing field of embolization indication.

"We are excited to count GEST as our most recent partner in the further development of the Endovascular Forum's clinical exchange platform," said Rony Sellam, Chief Strategy and Business Development Officer for IC Sciences. "The course directors' bold vision for applied learning and international diversity of perspectives is squarely aligned with the Forum's strengths and aspirations as we become the online destination of choice for cardiovascular and endovascular specialists worldwide."

The EVF and GEST collaboration will further continue to advance embolization knowledge and practice. This is a shared venture where an educational meeting and web-based forum combine to ensure that no part of this ever growing and developing discipline is left untouched.

About the Endovascular Forum. Founded in 1996, the Endovascular Forum is the world's longest standing medical forum dedicated to endovascular specialists. The EVF is an international case study and discussion forum developed and hosted by IC Sciences Corporation (www.ICSciences.com). The EVF members come together to share clinical observations, findings, and cases that all serve to accelerate the awareness and adoption of the most innovative and sometimes controversial procedures among physicians in the minimally invasive medical community. To learn more about the Endovascular Forum, visit www.Endovascular.org or call 866-804-6296.

About GEST

The GEST Meeting is the original and largest embolization meeting and the only one to focus upon a truly global and unique educational experience. It delivers the 'total' educational and professional know-how, by merging signature live demonstrations, master classes, hands-on attendee events, in-depth technical sessions, evidence-based review, research presentations, and case-based teaching. After three successful meetings in Europe, drawing thousands of total attendees from over 70 different countries, the meeting is coming to San Francisco from May 6 - 9, 2010. For more information about GEST, visit www.gestweb.org.

About IC Sciences Corporation. IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit: www.ICSciences.com.

    Contact:
    IC Sciences Corporation
    Public Relations
    (http://www.icsciences.com/contactus.cfm)
    One Joy Street
    Boston, MA 02108
    1-866-804-6296

SOURCE IC Sciences Corporation


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
4. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
7. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
8. Novavax to Present at 8th Annual BIO Investor Forum 2009
9. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
10. VirtualScopics to Present at the 8th Annual Bio Investor Forum
11. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 Automation is ... laboratory due to the growing demands for productivity in ... contemporary automated systems are already adept of a wide ... tedious and manual labor. Instrumentation continues to evolve, and ... conceivable just a few years ago. Originally used mostly ...
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
(Date:4/28/2016)... , April 28, 2016  The blood testing ... million dollars, according to Kalorama Information and The Freedonia ... immunoassays and nucleic acid testing.  The healthcare research firm ... progress in developing blood collection stations and in improving ... in Kalorama Information,s report, Blood Testing Market ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec Solutions will be a ... 18th at the Broward County Convention Center. The event is a chance for ... practices in public facility management. Intellitec Solutions will highlight their customized accounting solutions ...
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically ... aging – meaning that there is an urgent need for highly skilled care managers ... solution, delivering a multi-pronged approach to train and retain care managers, and enhance their ...
(Date:4/28/2016)... ... April 29, 2016 , ... Sublime Beauty® is offering a special deal on its webstore. ... off. The discount is applied to the product with lesser value. In addition, a ... purchase $250 or more in products. , "So many women (men, too) love our products ...
(Date:4/28/2016)... ... ... La Sirena Foods provides premium canned seafood, specifically, Tuna, Sardines and Mackerel. ... their market share in the USA. , "We are happy to have been selected ... and indirectly with Otis McAllister , a leading global food company," said GoMarketing ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... open availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. ... This innovative standard will make it possible to build applications that generate ...
Breaking Medicine News(10 mins):